Enhancing T Cell Chemotaxis and Infiltration in Glioblastoma

SIMPLE SUMMARY: Immunotherapy in glioblastoma has so far failed to yield a survival benefit. This failure can be attributed to a paucity of immune cells at the tumor site which can be reinvigorated to kill tumor cells. Therefore, driving effector immune cells such as cytotoxic T lymphocytes to the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Kirit, Hotchkiss, Kelly M., Patel, Kisha K., Wilkinson, Daniel S., Mohan, Aditya A., Cook, Sarah L., Sampson, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582389/
https://www.ncbi.nlm.nih.gov/pubmed/34771532
http://dx.doi.org/10.3390/cancers13215367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582389/
https://www.ncbi.nlm.nih.gov/pubmed/34771532
http://dx.doi.org/10.3390/cancers13215367

Ejemplares similares